Growth hormone receptor antagonists and fusion proteins thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11981719
APP PUB NO 20200399340A1
SERIAL NO

16954902

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a growth hormone receptor antagonist comprising a growth hormone variant which is modified by substitution of one or more amino acids of growth hormone. Further, the growth hormone receptor antagonist of the present invention may further comprise a long-acting carrier which is fused to the growth hormone variant. The growth hormone receptor antagonist may have strong binding potency to growth hormone receptor and may exhibit a long-lasting antagonistic action.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALTEOGEN INCDAEJEON DAEJEON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ko, Jaehyeong Daejeon, KR 2 1
Park, Soon Jae Daejeon, KR 21 105
You, Sun-Ah Daejeon, KR 3 7
Yun, Sang Hoon Daejeon, KR 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 14, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 14, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 14, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00